Variant report
Variant | nsv984209 |
---|---|
Chromosome Location | chr15:73098293-73108437 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:73095998..73099016-chr15:73347374..73350745,4 | MCF-7 | breast: | |
2 | chr15:73095643..73098434-chr15:73099404..73102029,2 | K562 | blood: | |
3 | chr15:73074471..73077912-chr15:73094314..73098768,4 | MCF-7 | breast: | |
4 | chr15:73095643..73098434-chr15:73099404..73102029,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000159322 | chromatin interactions |
ENSG00000260898 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532535912 | chr15:73098325-73098326 | ZNF genes & repeats Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs192178303 | chr15:73098327-73098328 | ZNF genes & repeats Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs572581485 | chr15:73098432-73098433 | ZNF genes & repeats Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs146862544 | chr15:73098453-73098454 | ZNF genes & repeats Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs542883844 | chr15:73098486-73098487 | ZNF genes & repeats Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs561785705 | chr15:73098509-73098510 | ZNF genes & repeats Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs373394396 | chr15:73098552-73098553 | ZNF genes & repeats Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs573674907 | chr15:73098568-73098569 | ZNF genes & repeats Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs543757015 | chr15:73098570-73098571 | ZNF genes & repeats Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs562152184 | chr15:73098623-73098624 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs61632994 | chr15:73098638-73098639 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs60686620 | chr15:73098639-73098640 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs184899939 | chr15:73098643-73098644 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs67979110 | chr15:73098648-73098649 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs61253039 | chr15:73098651-73098652 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs199579190 | chr15:73098652-73098653 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs551470115 | chr15:73098654-73098655 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs58512256 | chr15:73098655-73098656 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs188669880 | chr15:73098658-73098659 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs59530712 | chr15:73098685-73098686 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs560215559 | chr15:73098710-73098711 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs8034155 | chr15:73098820-73098821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527447866 | chr15:73098858-73098859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548928709 | chr15:73098935-73098936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567706510 | chr15:73098936-73098937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537964770 | chr15:73099082-73099083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550340354 | chr15:73099093-73099094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571667845 | chr15:73099103-73099104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539066109 | chr15:73099117-73099118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs8034552 | chr15:73099156-73099157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs8035936 | chr15:73099183-73099184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370673756 | chr15:73099185-73099186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374374771 | chr15:73099209-73099210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545845411 | chr15:73099245-73099246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs367920449 | chr15:73099269-73099270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554493557 | chr15:73099328-73099329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566346990 | chr15:73099400-73099401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192316075 | chr15:73099406-73099407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554865713 | chr15:73099430-73099431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528706470 | chr15:73099438-73099439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543892750 | chr15:73099454-73099455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555887045 | chr15:73099512-73099513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577195889 | chr15:73099515-73099516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78982400 | chr15:73099539-73099540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560367301 | chr15:73099545-73099546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs527594371 | chr15:73099547-73099548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542767023 | chr15:73099560-73099561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560917650 | chr15:73099571-73099572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570210190 | chr15:73099588-73099589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184474224 | chr15:73099597-73099598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 17133270 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Prostate cancer | 16573809 | CNVD |
Autism | 17322880 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Matthew-Wood syndrome | 21085971 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
phobic disorder | 16773131 | CNVD |
Autism | 21480499 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Mental retardation | 19951919 | CNVD |
Mental retardation | 16773131 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
15q24 microdeletion syndrome | 22180641 | CNVD |
15q24 microdeletion syndrome | 19921647 | CNVD |
Disease | 22216833 | CNVD |
Mental retardation | 17360722 | CNVD |
15q24 microdeletion syndrome | 22216833 | CNVD |
15q24 microdeletion syndrome | 22283845 | CNVD |
Developmental delay | 17932688 | CNVD |
craniofacial dysmorphism | 17932688 | CNVD |
digital and genital abnormalities | 17932688 | CNVD |
Mental retardation | 17621639 | CNVD |
Autism | 20808228 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Epilepsy | 22083797 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:73097200-73098600 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
2 | chr15:73097200-73098600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
3 | chr15:73097600-73099200 | Weak transcription | Fetal Intestine Small | intestine |
4 | chr15:73098200-73098400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
5 | chr15:73098200-73098600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr15:73098600-73100600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr15:73098600-73101000 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
8 | chr15:73098600-73112000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr15:73100600-73103000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
10 | chr15:73100800-73103000 | Enhancers | Primary T cells fromperipheralblood | blood |
11 | chr15:73101000-73102200 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
12 | chr15:73101000-73102400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
13 | chr15:73101200-73101800 | Enhancers | Primary B cells from peripheral blood | blood |
14 | chr15:73101200-73102200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
15 | chr15:73101200-73102400 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
16 | chr15:73101400-73102000 | Enhancers | Primary T helper cells fromperipheralblood | blood |
17 | chr15:73101400-73102400 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
18 | chr15:73101400-73102400 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
19 | chr15:73103600-73103800 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
20 | chr15:73105600-73105800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
21 | chr15:73105800-73117400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr15:73107400-73109200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
23 | chr15:73107400-73109800 | Enhancers | Placenta Amnion | Placenta Amnion |